{"id":"W2982296199","doi":"10.1016/s0140-6736(19)32597-8","title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1367,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Seattle Children's Research Institute; National Heart, Lung, and Blood Institute; Vertex Pharmaceuticals; National Institutes of Health; Cystic Fibrosis Foundation Therapeutics","keywords":"Ivacaftor; Cystic fibrosis; Regimen; Medicine; Double blind; Internal medicine; Mutation; Clinical trial; Genetics; Alternative medicine; Pathology; Biology; Cystic fibrosis transmembrane conductance regulator; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001470925,0.001586171,0.004459092,0.0005113393,0.0005036838,0.001170703,0.0009832334,0.003216463,0.006842018],"category_scores_gemma":[0.002242433,0.0007884736,0.002651338,0.0004272916,0.001488604,0.001302364,0.0004208142,0.003717651,0.001246815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006744761,"about_ca_system_score_gemma":0.0008155133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000998111,"about_ca_topic_score_gemma":0.001577697,"domain_scores_codex":[0.9992195,0.0003792336,0.000051395,0.0001603237,0.00006835706,0.0001212333],"domain_scores_gemma":[0.9991334,0.0002954589,0.0001970483,0.00007361892,0.00005628755,0.0002442139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9866651,0.002121339,0.0002920984,0.0003432222,0.0006585449,0.00002691356,0.00002855438,0.0001153636,0.001704809,0.00004772196,0.0003696722,0.007626676],"study_design_scores_gemma":[0.9640704,0.03410831,0.0009055038,0.0000242119,0.0003246295,0.00002144225,0.00001241207,0.0001137382,0.000136711,0.00007831544,0.0001930452,0.0000111759],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842121,0.008219447,0.0006869416,0.0008834808,0.0006711124,0.00188221,0.001088937,0.0001561599,0.002199602],"genre_scores_gemma":[0.9873262,0.00336937,0.0013444,0.001242964,0.0005064984,0.002355841,0.0008733575,0.00003417311,0.00294713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006842018,"threshold_uncertainty_score":0.02288884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03018850664270445,"score_gpt":0.3330470684773987,"score_spread":0.3028585618346943,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}